CMMB
Chemomab·NASDAQ
--
--(--)
--
--(--)
CMMB fundamentals
Chemomab (CMMB) released its earnings on Nov 21, 2025: revenue was -- (YoY 0.00%), beat estimates; EPS was -0.004 (YoY -140.00%), beat estimates.
Revenue / YoY
--
0.00%
EPS / YoY
-0.004
-140.00%
Report date
Nov 21, 2025
EPS
Revenue
Revenue & Expenses
Key Indicators
Chemomab (CMMB) key financial stats and ratios, covering profitability, financial health, and leverage.
Chemomab (CMMB)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Chemomab (CMMB)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Chemomab (CMMB)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does Chemomab (CMMB) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track Chemomab (CMMB) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield
You can ask Aime
What is Chemomab's latest dividend and current dividend yield?What is the revenue and EPS growth rate for Chemomab year over year?What were the key takeaways from Chemomab's earnings call?Did Chemomab beat or miss consensus estimates last quarter?What is the market's earnings forecast for Chemomab next quarter?What factors drove the changes in Chemomab's revenue and profit?What is Chemomab's gross profit margin?What were the key takeaways from Chemomab’s earnings call?
